Friday, March 13, 2026
Home Authors Posts by Ogkologos

Ogkologos

4166 POSTS 0 COMMENTS

Significant Intracranial Efficacy and Survival Benefits of Osimertinib in Patients with...

Ogkologos -
0

CAR22 Shows Durable Efficacy After a Single Infusion in Patients with...

Ogkologos -
0

FDA Approves HPV Tests That Allow for Self-Collection in a Health...

Ogkologos -
0

A Favourable Benefit-Risk Profile for Taletrectinib in TKI-Naїve and Crizotinib-Pretreated Patients...

Ogkologos -
0

FDA Approves Pembrolizumab with Chemotherapy for Primary Advanced or Recurrent Endometrial...

Ogkologos -
0

After 5 Years of Follow-Up, the Median PFS Has Yet To...

Ogkologos -
0

Adding Olanzapine to Standard Triple Antiemetic Therapy for the Prevention of...

Ogkologos -
0

Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy

Ogkologos -
0

EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab

Ogkologos -
0

Entrectinib Is Effective and Well Tolerated in Patients with Treatment-Naïve ROS1-positive...

Ogkologos -
0
1...525354...417Page 53 of 417

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com